October is Down Syndrome Awareness month. Its purpose is to raise public awareness of this common disorder and advocate for social acceptance and inclusion of people with Down syndrome. The estimated incidence of Down syndrome is between 1 in 1,000 to 1 in 1,100 live births worldwide. Each year, approximately 3,000 to 5,000 children are born with this chromosome disorder. The prevalence of Down syndrome increases with the mother’s age. It is associated with delays in physical growth, characteristic facial features and intellectual disability.

While Down syndrome cannot be cured, early treatment programs can help improve child skills. They may include speech, physical, occupational, and/or educational therapy.

By raising awareness and funding research, we can change the future of people with Down syndrome and their families.

Please contact us at bd@gctrials.com to find out more about GCT experience in genetic and pediatric diseases and how we can assist you in conducting a clinical trial.